News

Denovo Biomarkers, ALS-ETF to explore personalized medicine in amyotrophic lateral sclerosis

BY Alaric DeArment

SAN DIEGO — A biotech company and a nonprofit organization are looking into new ways to treat patients with the devastating degenerative disorder commonly known as Lou Gehrig’s disease.

The ALS Emergency Treatment Fund and Denovo Biomarkers announced Friday a deal to explore the use of personalized medicine in treating patients with the disease, known medically as amyotrophic lateral sclerosis. The two said the approach could accelerate drug development in ALS and other life-threatening disorders.

"This exciting relationship with Denovo Biomarkers may accelerate the development of drugs for ALS and may help us provide useful information for patients and physicians," ALS-ETF managing director Jess Rabourn said.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

AllerMates launches online community

BY Michael Johnsen

NANUET, N.Y. — AllerMates on Thursday launched an online community at AllerMates.com for parents and healthcare professionals to exchange experiences, seek advice, post recipes, get breaking news and alerts, make friends, share photos and videos, use the “ask the doctor platform” and create a strong support network of allies among others dealing with allergies and asthma. 

“The creation of an AllerMates online community was a natural extension of the benefits that AllerMates have brought to families with food allergies and other health ailments,” stated AllerMates CEO Iris Shamus. “Linking up with other kids and their families dealing with the ever-present challenges of allergies and asthma, especially during May’s Allergy and Asthma Awareness Month, gives people an important resource and lets them know they are not alone."

Among the many free features and resources on the site are a physician and professional directory, restaurant cards, action plans, downloadable schools signs and children’s activities.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

NCPA, McKesson to host three-day pharmacy ownership seminar

BY Michael Johnsen

ALEXANDRIA, Va. — The National Community Pharmacists Association on Thursday announced it will host its NCPA Ownership Workshop from May 17 to 19 at the Seattle Airport Marriott. The Ownership Workshop, sponsored by McKesson and in part by Pharmacists Mutual and Live Oak Bank, gives prospective and current pharmacy owners an in-depth look at the industry and the financial, management and marketing skills needed to operate a successful pharmacy business. The three-day session also offers pharmacists 20 hours of continuing education credits.

“Getting started in pharmacy ownership can be a daunting and sometimes discouraging venture when one does not have a familiarity with the process,” stated NCPA president Donnie Calhoun. “That’s why NCPA has designed this comprehensive workshop to be the best resource for any potential community pharmacy owners, including practicing pharmacists and pharmacy students, to hear directly from the experts about every facet of ownership — from finding the funding to purchase a pharmacy to how to successfully market your business once you open.”

Launched in 1991, Ownership Workshop is part of the multi-faceted, comprehensive NCPA Ownership Academy, which helps pharmacists navigate every step of the entrepreneurial process from buying to selling a pharmacy, as part of the association’s focus on increasing the number of independent community pharmacy owners throughout the country. More than 50% of previous Ownership Workshop participants now own their own pharmacy.


Are you a pharmacy technician working in the retail industry? Find our group on Facebook for more stories like this and join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?